Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Longitudinal Prospective Study of Neurocognitive Outcomes and Multimodal Quantitative Neuroimaging Outcomes in Primary Brain Tumor Patients Receiving Brain Radiotherapy

NCT05576103 is registered in ClinicalTrials.gov with Jona Hattangadi-Gluth as lead sponsor.

NCT NCT05576103
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05576103 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Longitudinal Prospective Study of Neurocognitive Outcomes and Multimodal Quantitative Neuroimaging Outcomes in Primary Brain Tumor Patients Receiving Brain Radiotherapy
Lead sponsor
Jona Hattangadi-Gluth
Phase
Observational
Overall status
Recruiting
Start date
January 31, 2015
Completion date
December 31, 2030
Enrollment
300 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

glioma, meningioma, primary brain tumor, schwannoma